"Though financial conflicts of interest are not at all new to politics, this one is particularly tricky because Ozempic and its weight loss sister drug Wegovy are currently not covered by Medicare or Medicaid and can end up costing nearly $1,000 per month without insurance."
"The situation could be an ethical morass," Shaub told WaPo, "unless he is truly willing to alter his finances and business dealing."
Collection
[
|
...
]